Assessing mortality and safety of IV thrombolysis in ischemic stroke patients on direct oral anticoagulants (DOACs): A systematic review and meta-analysis
- 11 September 2024
- journal article
- review article
- Published by Elsevier in Clinical Neurology and Neurosurgery
- Vol. 246, 108523
Abstract
No abstract availableKeywords
This publication has 50 references indexed in Scilit:
- Building Evidence on Safety of Thrombolysis for Patients Undergoing Direct Oral Anticoagulant TreatmentJAMA Neurology, 2023
- Association of Recent Use of Non–Vitamin K Antagonist Oral Anticoagulants With Intracranial Hemorrhage Among Patients With Acute Ischemic Stroke Treated With AlteplaseJAMA, 2022
- Prior Anticoagulation in Patients with Ischemic Stroke and Atrial FibrillationAnnals of Neurology, 2020
- Management of patients with stroke treated with direct oral anticoagulantsJournal of Neurology, 2018
- Thrombolysis for acute ischaemic strokeCochrane Database of Systematic Reviews, 2014
- Safety of intravenous thrombolysis for ischemic stroke in patients treated with warfarinAnnals of Neurology, 2013
- Recommendations for the emergency management of complications associated with the new direct oral anticoagulants (DOACs), apixaban, dabigatran and rivaroxabanClinical Research in Cardiology, 2013
- Risks of Intracranial Hemorrhage Among Patients With Acute Ischemic Stroke Receiving Warfarin and Treated With Intravenous Tissue Plasminogen ActivatorJAMA, 2012
- Thrombolysis with recombinant tissue plasminogen activator under dabigatran anticoagulation in experimental strokeAnnals of Neurology, 2012
- Blood–brain barrier breakdown and repair by Src after thrombin‐induced injuryAnnals of Neurology, 2010